tiprankstipranks
Advertisement
Advertisement

ROIV Stock Latest News

Roivant Advances Brepocitinib Program, Refocuses Autoimmune Portfolio
Company AnnouncementsRoivant Advances Brepocitinib Program, Refocuses Autoimmune Portfolio
3d ago
8K
ROIV
Roivant reports new clinical program for brepocitinib in lichen planopilaris
PremiumThe Fly
Roivant reports new clinical program for brepocitinib in lichen planopilaris
3d ago
ROIV
Bernstein bullish on Roivant Sciences, initiates with an Outperform
PremiumThe Fly
Bernstein bullish on Roivant Sciences, initiates with an Outperform
16d ago
ROIV
Roivant Sciences initiated with an Outperform at Bernstein
PremiumThe Fly
Roivant Sciences initiated with an Outperform at Bernstein
17d ago
ROIV
Roivant Sciences price target raised to $33 from $31 at JPMorgan
PremiumThe Fly
Roivant Sciences price target raised to $33 from $31 at JPMorgan
1M ago
ROIV
Midday Fly By: Stocks climb as oil prices pull back
PremiumThe FlyMidday Fly By: Stocks climb as oil prices pull back
1M ago
F
BW
Video: Moderna advances as settlement seen removing share overhang
Premium
The Fly
Video: Moderna advances as settlement seen removing share overhang
1M ago
ABUS
GTLB
Morning Movers: Moderna rises after entering COVID settlement agreement
Premium
The Fly
Morning Movers: Moderna rises after entering COVID settlement agreement
1M ago
ANF
BBW
Unlocking Value from IP Settlement and Pipeline Catalysts: Why Roivant Deserves a Buy Rating
PremiumRatings
Unlocking Value from IP Settlement and Pipeline Catalysts: Why Roivant Deserves a Buy Rating
1M ago
ROIV
Moderna resolves litigation with Arbutus, to pay up to $2.25B in settlement
PremiumThe Fly
Moderna resolves litigation with Arbutus, to pay up to $2.25B in settlement
1M ago
ABUS
MRNA
Roivant Sciences price target raised to $29 from $26 at BofA
PremiumThe Fly
Roivant Sciences price target raised to $29 from $26 at BofA
1M ago
ABUS
MRNA
Roivant Sciences price target raised to $34 from $33 at H.C. Wainwright
PremiumThe Fly
Roivant Sciences price target raised to $34 from $33 at H.C. Wainwright
1M ago
ROIV
Roivant: Strengthened Cash Position Post‑Moderna Settlement but Limited Upside Keeps Rating at Hold
PremiumRatingsRoivant: Strengthened Cash Position Post‑Moderna Settlement but Limited Upside Keeps Rating at Hold
1M ago
ROIV
Roivant Subsidiary Reaches Major Global Patent Settlement
Premium
Company Announcements
Roivant Subsidiary Reaches Major Global Patent Settlement
1M ago
8K
ROIV
Genevant, Arbutus announce $2.25B global settlement with Moderna
Premium
The Fly
Genevant, Arbutus announce $2.25B global settlement with Moderna
1M ago
ABUS
MRNA
Roivant’s Priovant Unit Gains FDA Priority Review for Brepocitinib
PremiumCompany Announcements
Roivant’s Priovant Unit Gains FDA Priority Review for Brepocitinib
1M ago
8K
ROIV
Roivant Sciences announces U.S. FDA accepted its NDA for brepocitinib
PremiumThe Fly
Roivant Sciences announces U.S. FDA accepted its NDA for brepocitinib
1M ago
ROIV
Roivant Sciences price target raised to $35 from $26 at Citi
PremiumThe Fly
Roivant Sciences price target raised to $35 from $26 at Citi
2M ago
ROIV
Roivant Sciences price target raised to $33 from $26 at H.C. Wainwright
PremiumThe Fly
Roivant Sciences price target raised to $33 from $26 at H.C. Wainwright
2M ago
ROIV
Roivant Sciences Earnings Call Highlights Brepocitinib Surge
PremiumCompany AnnouncementsRoivant Sciences Earnings Call Highlights Brepocitinib Surge
2M ago
ROIV
Roivant Sciences price target raised to $26 from $22 at BofA
Premium
The Fly
Roivant Sciences price target raised to $26 from $22 at BofA
2M ago
ROIV
Roivant Sciences price target raised to $30 from $24 at Jefferies
Premium
The Fly
Roivant Sciences price target raised to $30 from $24 at Jefferies
2M ago
ROIV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >